20273 results for «»

Filter By

20273 results

Luis Jhonathan Uribe González

Mexico, Mexico

Rutao Wang

Xi'an, China

Williams Paul

Middlesbrough, United Kingdom

Tobias Ruf

Mainz, Germany

Gualter Santos Silva

Vila Nova de Gaia, Portugal

Cláudia Silva

Carnaxide, Portugal

Tian-Yuan (april) Xiong

Chengdu, China

Magda Zadrozny

Munich, Germany

Ivan Wong

Hong Kong

Jessielyn Sia

Metro Manila, Philippines

Dave Smith

Swansea, United Kingdom

Alexander R. Tamm

Mainz, Germany

#PCRValves: Digital coverage of PCR Valves e-Course 2020

Ensure that you stay up to date on what’s new in percutaneous valve interventions and valvular heart disease thanks to this coverage by the #PCRValves Social Media Team!
Digital coverage

STEMI and COVID-19: when two potential killers join up

11 Nov 2020

Is COVID responsible for myocardial injury (including STEMI) or is it an innocent bystander? View this case of a male patient, 70+ years with clear COVID symptoms for several days, presenting with chest pain starting about 3h before admission. Past history: permanent Afib on Eliquis.

Dr. Marko Noc

Author

Marko Noc
STEMI and COVID-19: when two potential killers join up

PCR Valves e-Course 2020 - Exhibitor List

Discover which valued Industry Partners you will be able to interact with in the #PCRvalves virtual Exhibition on 22, 23, 24 November 2020!
PCR Valves e-Course 2020 - Exhibitor List

Percutaneous coronary intervention for vulnerable coronary atherosclerotic plaque

30 Nov 2020

Do you have any experience with NIRS technology? Do you think that use of 3rd generation DES would have shown better results than BVS? Read this review by S. Brugaletta

Reviewer

Salvatore Brugaletta
PCI for vulnerable coronary atherosclerotic plaque

Cangrelor, Tirofiban and Chewed or Standard Prasugrel Regimens in Patients with ST-Segment Elevation Myocardial Infarction: Primary Results of the FABOLUS FASTER Trial

15 Jul 2020

The results of the FABOLUS FASTER trial clearly highlight that a high residual platelet reactivity persists when targeting platelet activation by inhibition of the P2Y12 receptor either with Prasugrel or Cangrelor, while tackling the mechanism of platelet adhesion thought the inhibition of GPIIB/IIIA might almost completely...

Luigi Biasco

Reviewer

Luigi Biasco
Primary Results of the FABOLUS FASTER Trial

Abstracts on other coronary interventions - PCR e-Course 2020

25 Jun 2020 – From PCR e-Course 2020

View a selection of abstracts from PCR e-Course 2020 on the topic of Other coronary interventions:

  • PCI with robotic assistance: the first 100 patients at Clinique Pasteur
  • Safety and efficacy of sirolimus coated balloon in patients with CAD
Abstracts on Other coronary interventions - PCR e-Course 2020

Current evidence for the interventional treatment of INOCA patients

26 Jun 2020 – From PCR e-Course 2020

Watch this session if you want to understand how Reducer therapy can help the interventionalist safely improve symptoms of his "end stage" patient, to recognize that microvascular disease is common and has poor prognosis and to understand how Reducer therapy can address patients with microvascular disease.

Current evidence for the interventional treatment of INOCA patients

Ultra low contrast: new skills and technologies for next frontier in PCI

27 Jun 2020 – From PCR e-Course 2020

Watch this session if you want to learn why ULCPCI will be needed for patients who have developed cardiomyopathy due wait linked to COVID outbreak, to understand what tools we have in the cathlab to perform ULCPCI and to learn how to practice ultra-low contrast in...

Ultra low contrast: new skills and technologies for next frontier in PCI
Didn’t find what you were looking for?